Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis [NA]
A terminated clinical trial evaluating transcranial direct current stimulation for reducing neuropathic pain in people with multiple scleros…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS [NA]
A terminated clinical trial evaluating activity and balanced eating to reduce comorbidities and symptoms in people with multiple sclerosis; …
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS [Phase 2]
Phase 2 trial assessing repeated administration of NurOwn (MSC-NTF cells) for progressive multiple sclerosis; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: FMT for MS Patients [Phase 2]
Phase 2 clinical trial update for fecal microbiota transplantation in multiple sclerosis patients; status information is currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV [Phase 4]
Phase 4 clinical trial update for the MAIN STUDY: SWITCH sub-study SWITCH-JCV in multiple sclerosis has completed with results posted in 202…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis [Phase 3]
Phase 3 trial update for Xacrel (Ocrelizumab) in relapsing-remitting multiple sclerosis reports efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS) [Phase 4]
Phase 4 trial update on discontinuation of disease-modifying therapies (DMTs) in multiple sclerosis, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Vaginal Estriol in Multiple Sclerosis [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating vaginal estriol for multiple sclerosis and neurogenic bladder has results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating lisdexamfetamine sulfate for cognitive dysfunction in multiple sclerosis has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: CPAP to Treat Cognitive Dysfunction in MS [NA]
Clinical trial investigating CPAP treatment for cognitive dysfunction in multiple sclerosis has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis [NA]
A completed clinical trial evaluating transcranial direct current stimulation (tDCS) to reduce neuropathic pain and fatigue in people with m…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial evaluating botulinum toxin for spastic lower limb paresis in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS [Phase 3]
Phase 3 trial investigating the safety and effectiveness of arbaclofen extended-release tablets in patients with multiple sclerosis-related …
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS [Phase 3]
Phase 3 trial assessing long-term safety of arbaclofen extended-release tablets for spasticity due to multiple sclerosis; study completed wi…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT [Phase 3]
A Phase 3 study evaluating alemtuzumab in pediatric relapsing-remitting multiple sclerosis with disease activity on prior disease-modifying …
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 [Phase 3]
Phase 3 trial update for ALKS 8700 in adults with relapsing-remitting multiple sclerosis (EVOLVE-MS-1) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) [Phase 4]
Phase 4 clinical trial assessing Tecfidera in radiologically isolated syndrome completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) [Phase 4]
Phase 4 clinical trial assessing long-term outcomes and durability of effect after cladribine tablets in multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) [Phase 2]
Phase 2 trial evaluating BIIB033 (Opicinumab) as add-on therapy to existing disease-modifying therapies in relapsing multiple sclerosis; stu…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis [Phase 3]
Phase 3 trial update evaluating arbaclofen for spasticity in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity [Phase 3]
Phase 3 open-label dose-escalation long-term safety study in multiple sclerosis patients with spasticity completed.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) [Phase 3]
Phase 3 trial of laquinimod in relapsing-remitting multiple sclerosis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous bone marrow-derived mesenchymal cells given intravenously in patients with multiple sclerosis has comp…
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Famciclovir in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for famciclovir in multiple sclerosis is ongoing with unknown status.